Evaluation of Various Doses of Ro 27-2771 (Test Drug) in Asthmatic Patients Not Treated With Inhaled Corticosteroids

NCT00048009 | Completed Phase 2

• 1 other identifier: BA16631
• Study Type: interventional
• Target: N/A
• Locations: 5 countries
• Sites: 91

Brief Summary

The purpose of this study is to determine the appropriate dose of Ro 27-2441 (test drug) to be used in future studies, assess the efficacy and safety, and the anti-inflammatory action of the test drug in the treatment of asthmatic patients who are not currently receiving chronic therapy with corticosteroids. The research is being conducted at up to 80 clinical research sites in the US, Mexico, and Canada. Study participants will have a number of visits to a research site over approximately a 4-month period.

Conditions

Asthma

Interventions

Dual Integrin Antagonist DRUG

Eligibility Criteria

• Age: 18 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Persistent asthma for more than one year
• Current treatment for asthma with short acting inhaled beta 2 agonists (such as albuterol) only
• In good health ad demonstrated by medical history and physical exam
• Negative urine pregnancy test
• Commitment to use two forms of effective contraception simultaneously throughout the study duration and for one month after discontinuing therapy

You may not qualify if:

• Asthma necessitating treatment with inhaled corticosteroids for at least one month before the start of the study
• History of severe asthma necessitating the use of oral/injectable corticosteroids within the last 2 months and/and or two bursts in the last year
• Undergoing allergy shots unless on a stable maintenance dose for three months before the start of the study
• History of chronic pulmonary diseases other than asthma
• Treatment of conditions other than asthma with oral corticosteroids within one month of the start of the study
• Current tobacco use
• Smoking history of greater than 10 pack-year history of cigarette smoking (number of packs smoked per day times the number of years smoked)
• History or evidence of drug or alcohol abuse
• Diagnosis or evidence of an infectious illness within one month of Visit 1
• Clinically significant diseases as assessed by the study doctor
• Participation in another clinical study with an experimental drug within one month of start of the study

Sponsors & Collaborators

• Hoffmann-La Roche: lead

Study Sites (91)

Unknown Facility

Scottsdale, Arizona, 85251, United States

Location

Unknown Facility

Huntington Beach, California, 92647, United States

Location

Unknown Facility

Long Beach, California, 90806, United States

Location

Unknown Facility

Los Angeles, California, 90025, United States

Location

Unknown Facility

Los Angeles, California, 90095-1690, United States

Location

Unknown Facility

Palmdale, California, 93551, United States

Location

Unknown Facility

San Diego, California, 92103, United States

Location

Unknown Facility

San Diego, California, 92120, United States

Location

Unknown Facility

San Diego, California, 92123, United States

Location

Unknown Facility

San Jose, California, 95128, United States

Location

Unknown Facility

Walnut Creek, California, 94598, United States

Location

Unknown Facility

Denver, Colorado, 80206, United States

Location

Unknown Facility

Denver, Colorado, 80230, United States

Location

Unknown Facility

Louisville, Colorado, 80027, United States

Location

Unknown Facility

Wheat Ridge, Colorado, 80033, United States

Location

Unknown Facility

Hartford, Connecticut, 06106, United States

Location

Unknown Facility

Tallahassee, Florida, 32308, United States

Location

Unknown Facility

Tamarac, Florida, 33321, United States

Location

Unknown Facility

Tampa, Florida, 33609, United States

Location

Unknown Facility

Tampa, Florida, 33613, United States

Location

Unknown Facility

Atlanta, Georgia, 30309, United States

Location

Unknown Facility

Savannah, Georgia, 31406, United States

Location

Unknown Facility

Chicago, Illinois, 60637-1470, United States

Location

Unknown Facility

Normal, Illinois, 61761, United States

Location

Unknown Facility

River Forest, Illinois, 60305, United States

Location

Unknown Facility

Indianapolis, Indiana, 46208, United States

Location

Unknown Facility

Iowa City, Iowa, 52240, United States

Location

Unknown Facility

Lenexa, Kansas, 66219, United States

Location

Unknown Facility

Metairie, Louisiana, 70006, United States

Location

Unknown Facility

North Dartmouth, Massachusetts, 02745, United States

Location

Unknown Facility

Minneapolis, Minnesota, 55402, United States

Location

Unknown Facility

St Louis, Missouri, 63141, United States

Location

Unknown Facility

Missoula, Montana, 59804, United States

Location

Unknown Facility

Omaha, Nebraska, 68114, United States

Location

Unknown Facility

Las Vegas, Nevada, 89104, United States

Location

Unknown Facility

Cherry Hill, New Jersey, 08003, United States

Location

Unknown Facility

Princeton, New Jersey, 08540, United States

Location

Unknown Facility

Teaneck, New Jersey, 07666, United States

Location

Unknown Facility

Farmingdale, New York, 11735, United States

Location

Unknown Facility

Rochester, New York, 14618, United States

Location

Unknown Facility

Rockville Centre, New York, 11570, United States

Location

Unknown Facility

Elizabeth City, North Carolina, 27909, United States

Location

Unknown Facility

Canton, Ohio, 44718, United States

Location

Unknown Facility

Cincinnati, Ohio, 45231, United States

Location

Unknown Facility

Medford, Oregon, 97504, United States

Location

Unknown Facility

Portland, Oregon, 97213, United States

Location

Unknown Facility

Easton, Pennsylvania, 18045, United States

Location

Unknown Facility

Philadelphia, Pennsylvania, 19115, United States

Location

Unknown Facility

Philadelphia, Pennsylvania, 19140, United States

Location

Unknown Facility

Upland, Pennsylvania, 19013, United States

Location

Unknown Facility

Providence, Rhode Island, 02906, United States

Location

Unknown Facility

Charleston, South Carolina, 29407, United States

Location

Unknown Facility

Charleston, South Carolina, 29425, United States

Location

Unknown Facility

Austin, Texas, 78750, United States

Location

Unknown Facility

Dallas, Texas, 75231, United States

Location

Unknown Facility

Dallas, Texas, 75240, United States

Location

Unknown Facility

El Paso, Texas, 79925, United States

Location

Unknown Facility

San Antonio, Texas, 78229, United States

Location

Unknown Facility

Sugar Land, Texas, 77478, United States

Location

Unknown Facility

Murray, Utah, 84107, United States

Location

Unknown Facility

Kirkland, Washington, 98034, United States

Location

Unknown Facility

Seattle, Washington, 98105, United States

Location

Unknown Facility

Spokane, Washington, 99202, United States

Location

Unknown Facility

Tacoma, Washington, 98405, United States

Location

Unknown Facility

Wenatchee, Washington, 98801, United States

Location

Unknown Facility

Morgantown, West Virginia, 26505, United States

Location

Unknown Facility

Madison, Wisconsin, 53792-9988, United States

Location

Unknown Facility

Milwaukee, Wisconsin, 53209, United States

Location

Unknown Facility

Adelaide, 5000, Australia

Location

Unknown Facility

Brisbane, 4102, Australia

Location

Unknown Facility

Melbourne, 3050, Australia

Location

Unknown Facility

Perth, 6009, Australia

Location

Unknown Facility

Sydney, 2139, Australia

Location

Unknown Facility

Woodville, 5011, Australia

Location

Unknown Facility

Vancouver, British Columbia, V5Z 1M9, Canada

Location

Unknown Facility

Hamilton, Ontario, L8N 4A6, Canada

Location

Unknown Facility

Toronto, Ontario, M5S 2A5, Canada

Location

Unknown Facility

Toronto, Ontario, M6H 3M2, Canada

Location

Unknown Facility

Montreal, Quebec, H4J 1C5, Canada

Location

Unknown Facility

Québec, Quebec, O1V 4G5, Canada

Location

Unknown Facility

Chihuahua City, 31000, Mexico

Location

Unknown Facility

Guadalajara, 44600, Mexico

Location

Unknown Facility

Mexico City, 06700, Mexico

Location

Unknown Facility

Mexico City, 06720, Mexico

Location

Unknown Facility

Mexico City, 14050, Mexico

Location

Unknown Facility

Mérida, Mexico

Location

Unknown Facility

México, 14080, Mexico

Location

Unknown Facility

Monterrey, 64000, Mexico

Location

Unknown Facility

Monterrey, 64710, Mexico

Location

Unknown Facility

Puebla City, 72000, Mexico

Location

Unknown Facility

Ponce, 00732, Puerto Rico

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Study Design

• Study Type: interventional
• Phase: phase 2
• Purpose: TREATMENT
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 24, 2002
• First Posted: October 25, 2002
• Study Start: October 25, 2002
• Primary Completion: February 2, 2004
• Study Completion: February 2, 2004
• Last Updated: June 19, 2017

Record last verified: 2017-02

Locations

PR (1); CA (6); US (68); AU (6); ME (10)